Opiate Antagonists ValueSet Definition: Including Drug Information like Buprenorphine
ValueSet '2.16.840.1.113883.3.464.1003.196.11.1529' (1) - R4 - Ontoserver
Summary
The definition for a ValueSet titled 'Opiate Antagonists' has been published by NCQA PHEMUR. This ValueSet includes multiple drug codes related to opioid antagonists, such as buprenorphine and naltrexone, which aids in standardizing medical information.
Details
This page provides reference information for a FHIR ValueSet defining the drug group 'Opiate Antagonists'. The ValueSet encompasses multiple pharmaceutical codes (e.g., 1010600 buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film), including opioid antagonists like buprenorphine and naltrexone. Technically, it is provided in the FHIR ValueSet resource format and references the UMLS (Unified Medical Language System) RxNorm system. This enables healthcare institutions and IT systems to exchange and utilize this drug information in a standardized manner. This information provides a foundation for standardizing medication protocols and data exchange, particularly in opioid use disorder treatment, which is relevant for ensuring international compatibility of Japanese electronic medical records and dispensing systems. The ValueSet is marked as 'Active' and published by NCQA PHEMUR. The included concepts detail specific dosages and formulations of multiple drugs, supporting accurate medication documentation and data exchange in clinical settings. This reference defines a set of standard concepts (ValueSet) based on the FHIR specification, publishing its structure and detailed drug information for a specific clinical domain.
Original content copyright by respective publishers